Drug intelligence / Profile preview

2,3-Dimercapto-1-propanesulfonic acid

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

**2,3-Dimercapto-1-propanesulfonic acid (DMPS)** is a small molecule chelating agent used primarily as an antidote for heavy metal poisoning. It acts by binding to heavy metal ions such as mercury and arsenic through its thiol groups to form stable water-soluble complexes that are then excreted from the body[6][4][5]. The sodium salt of DMPS is known as Unithiol. DMPS has been investigated for use in both acute and chronic intoxications by arsenic and mercury compounds[4], and has shown efficacy in reducing body burden of these metals in clinical settings[2]. It is related structurally to dimercaprol but offers improved water solubility. While it can lower urinary mercury levels effectively[2], it may not be effective at removing intracellular or brain-bound mercury. Additionally, preclinical studies suggest potential repurposing for early intervention after hemotoxic snakebite envenomation due to its metal-chelating properties[2]. Adverse effects are rare but can include severe reactions such as Stevens–Johnson syndrome.

Brand names
Unithiol
Other names
DL-2,3-dimercaptopropane-1-sulfonic acid2,3-dimercaptopropane-1-sulfonic acid2,3-disulfanylpropane-1-sulfonic acid2,3-dimercapto-1-propane sulfonate2,3-dimercaptopropan-1-sulfonsaeure
02

Targets

OAT1 (Organic anion transporter 1)

Beyond the preview

Go deeper on 2,3-Dimercapto-1-propanesulfonic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,3-Dimercapto-1-propanesulfonic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call